Why is RNXT Up Today?
About RenovoRx, Inc. Common Stock
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is de...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -1.6%
Market Comparison
🔔 Get RNXT Alerts
We'll notify you when RNXT's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
RNXT has moved more than 3.0% up on 55 occasions in the past year.
Frequently Asked Questions
Why is RNXT stock up today?
This stock is significantly outperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is RNXT stock a buy or sell right now?
Based on current analysis, RNXT shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the RNXT stock price target?
RNXT is currently trading at $1.59. Based on today's momentum, the expected short-term range is $1.55 - $1.63. See long-term price prediction →
Will RNXT stock continue rising?
Our analysis shows a 45% probability that RNXT's move continues in the next 1-3 days. Key level to watch: $1.66 (resistance).
Is RNXT stock oversold or overbought?
RNXT's RSI (Relative Strength Index) is currently at 47.4. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for RNXT stock?
RNXT's 10-day momentum indicator is at -0.11. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is RNXT outperforming or underperforming the market?
RNXT (+2.26%) is currently outperforming the market (+1.5% vs SPY). Today, the S&P 500 (SPY) is up 0.74%, and Nasdaq (QQQ) is up 1.02%.
What does MACD indicate for RNXT?
RNXT's MACD (-0.01) is currently below the signal line (0.04), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 24.6) is moderate.
Is RNXT in an uptrend or downtrend?
Based on moving average analysis, RNXT is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $1.73, 50-day SMA: $1.49.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis